Orthopedic Surgery Doctors in Damariscotta, ME Accepting Medicare

5 Orthopedic Surgery doctors found. Showing 1 - 5

Sean J. Moran, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Miles Center Way, Damariscotta, ME 04543 Phone: 207-563-1040    Fax: 207-563-1039

Dr. Eric Matthew Johnson, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Miles Center Way, Damariscotta, ME 04543 Phone: 207-661-2018

Dr. Aaron Samuel Vaslow, M.D. Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 24 Miles Center Way, Damariscotta, ME 04543 Phone: 207-563-1234

Rifat A. Zaidi, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Miles Center Way, Damariscotta, ME 04543 Phone: 207-563-1040    Fax: 207-563-1039

Edward R. White, M.D. Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 24 Miles Center Way, Damariscotta, ME 04543 Phone: 207-563-1040    Fax: 207-563-1039

News Archive

Children of imprisoned mothers generally have insecure relationships with their mothers and caregivers

Children of imprisoned mothers generally have insecure relationships with their mothers and caregivers, according to a new study published in the May/June issue of the journal Child Development. However, the children were more likely to have secure relationships with their caregivers if they were living in a stable environment.

Canadian federal government to renew Aboriginal Diabetes Initiative

The Canadian Diabetes Association and the National Aboriginal Diabetes Association applaud the federal government for its decision to renew the Aboriginal Diabetes Initiative (ADI) as presented in the budget announcement on March 4.

LGBQ adolescents more likely to attempt suicide than heterosexual peers

Adolescents who identify as gay, lesbian, bisexual or questioning are much more likely to consider, plan or attempt suicide than their heterosexual peers, according to research from the University of Pennsylvania, the University of California, San Diego, and San Diego State University published this week in the Journal of the American Medical Association.

Afferent Pharmaceuticals' P2X3 receptor antagonist reduces bladder hyperactivity

Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecule compounds that target P2X3 receptors, today announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist reduced experimentally induced bladder hyperactivity.

Read more Medical News

› Verified 6 days ago